Literature DB >> 31160495

Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers-Response.

Anu Sharma1, Sumit K Subudhi1, Jorge Blando2, Luis Vence2, Jennifer Wargo3, James P Allison2, Antoni Ribas4, Padmanee Sharma5,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31160495      PMCID： PMC6662573          DOI： 10.1158/1078-0432.CCR-19-0402

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  18 in total

Review 1.  Modulation of regulatory T cell function and stability by co-inhibitory receptors.

Authors:  Liliana E Lucca; Margarita Dominguez-Villar
Journal:  Nat Rev Immunol       Date:  2020-04-08       Impact factor: 53.106

Review 2.  Charting roadmaps towards novel and safe synergistic immunotherapy combinations.

Authors:  Miguel F Sanmamed; Pedro Berraondo; Maria E Rodriguez-Ruiz; Ignacio Melero
Journal:  Nat Cancer       Date:  2022-06-28

3.  Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma.

Authors:  Catherine S Grasso; Jennifer Tsoi; Mykola Onyshchenko; Gabriel Abril-Rodriguez; Petra Ross-Macdonald; Megan Wind-Rotolo; Ameya Champhekar; Egmidio Medina; Davis Y Torrejon; Daniel Sanghoon Shin; Phuong Tran; Yeon Joo Kim; Cristina Puig-Saus; Katie Campbell; Agustin Vega-Crespo; Michael Quist; Christophe Martignier; Jason J Luke; Jedd D Wolchok; Douglas B Johnson; Bartosz Chmielowski; F Stephen Hodi; Shailender Bhatia; William Sharfman; Walter J Urba; Craig L Slingluff; Adi Diab; John B A G Haanen; Salvador Martin Algarra; Drew M Pardoll; Valsamo Anagnostou; Suzanne L Topalian; Victor E Velculescu; Daniel E Speiser; Anusha Kalbasi; Antoni Ribas
Journal:  Cancer Cell       Date:  2020-09-10       Impact factor: 31.743

4.  The role and therapeutic implications of T cells in cancer of the lung.

Authors:  Samuel C Neeve; Bruce Ws Robinson; Vanessa S Fear
Journal:  Clin Transl Immunology       Date:  2019-08-28

5.  Siah2 control of T-regulatory cells limits anti-tumor immunity.

Authors:  Marzia Scortegagna; Kathryn Hockemeyer; Igor Dolgalev; Joanna Poźniak; Florian Rambow; Yan Li; Yongmei Feng; Roberto Tinoco; Dennis C Otero; Tongwu Zhang; Kevin Brown; Marcus Bosenberg; Linda M Bradley; Jean-Christophe Marine; Ioannis Aifantis; Ze'ev A Ronai
Journal:  Nat Commun       Date:  2020-01-07       Impact factor: 14.919

Review 6.  Lysophosphatidic Acid Is an Inflammatory Lipid Exploited by Cancers for Immune Evasion via Mechanisms Similar and Distinct From CTLA-4 and PD-1.

Authors:  Divij Mathew; Raul M Torres
Journal:  Front Immunol       Date:  2021-01-27       Impact factor: 7.561

7.  Intratumoral Combinatorial Administration of CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Ipilimumab and Avelumab in Combination with Intravenous Low-Dose Nivolumab in Patients with Advanced Solid Tumors: A Phase IB Clinical Trial.

Authors:  Julia Katharina Schwarze; Gil Awada; Louise Cras; Jens Tijtgat; Ramses Forsyth; Inès Dufait; Sandra Tuyaerts; Ivan Van Riet; Bart Neyns
Journal:  Vaccines (Basel)       Date:  2020-11-10

Review 8.  Single-Cell Approaches to Profile the Response to Immune Checkpoint Inhibitors.

Authors:  Lara Gibellini; Sara De Biasi; Camillo Porta; Domenico Lo Tartaro; Roberta Depenni; Giovanni Pellacani; Roberto Sabbatini; Andrea Cossarizza
Journal:  Front Immunol       Date:  2020-03-20       Impact factor: 7.561

9.  TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma.

Authors:  Brenda De Keersmaecker; Sofie Claerhout; Javier Carrasco; Isabelle Bar; Jurgen Corthals; Sofie Wilgenhof; Bart Neyns; Kris Thielemans
Journal:  J Immunother Cancer       Date:  2020-02       Impact factor: 13.751

10.  Conducting a Virtual Clinical Trial in HER2-Negative Breast Cancer Using a Quantitative Systems Pharmacology Model With an Epigenetic Modulator and Immune Checkpoint Inhibitors.

Authors:  Hanwen Wang; Richard J Sové; Mohammad Jafarnejad; Sondra Rahmeh; Elizabeth M Jaffee; Vered Stearns; Evanthia T Roussos Torres; Roisin M Connolly; Aleksander S Popel
Journal:  Front Bioeng Biotechnol       Date:  2020-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.